These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 21167484)
1. Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies. Fiechter M; Frey K; Fugmann T; Kaufmann PA; Neri D Atherosclerosis; 2011 Feb; 214(2):325-30. PubMed ID: 21167484 [TBL] [Abstract][Full Text] [Related]
2. Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies. Pedretti M; Rancic Z; Soltermann A; Herzog BA; Schliemann C; Lachat M; Neri D; Kaufmann PA Atherosclerosis; 2010 Feb; 208(2):382-9. PubMed ID: 19699478 [TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin. Matter CM; Schuler PK; Alessi P; Meier P; Ricci R; Zhang D; Halin C; Castellani P; Zardi L; Hofer CK; Montani M; Neri D; Lüscher TF Circ Res; 2004 Dec; 95(12):1225-33. PubMed ID: 15539632 [TBL] [Abstract][Full Text] [Related]
4. Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo. von Lukowicz T; Silacci M; Wyss MT; Trachsel E; Lohmann C; Buck A; Lüscher TF; Neri D; Matter CM J Nucl Med; 2007 Apr; 48(4):582-7. PubMed ID: 17401095 [TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice. Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640 [TBL] [Abstract][Full Text] [Related]
6. Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin. Bültmann A; Li Z; Wagner S; Peluso M; Schönberger T; Weis C; Konrad I; Stellos K; Massberg S; Nieswandt B; Gawaz M; Ungerer M; Münch G J Mol Cell Cardiol; 2010 Sep; 49(3):532-42. PubMed ID: 20430036 [TBL] [Abstract][Full Text] [Related]
7. The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel. Pasche N; Wulhfard S; Pretto F; Carugati E; Neri D Clin Cancer Res; 2012 Aug; 18(15):4092-103. PubMed ID: 22693354 [TBL] [Abstract][Full Text] [Related]
8. Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis. Dietrich T; Berndorff D; Heinrich T; Hucko T; Stepina E; Hauff P; Dinkelborg LM; Atrott K; Giovannoni L; Neri D; Fleck E; Graf K; Menssen HD Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):228-37. PubMed ID: 25864530 [TBL] [Abstract][Full Text] [Related]
9. Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6. Hess C; Neri D Protein Eng Des Sel; 2014 Jun; 27(6):207-13. PubMed ID: 24795343 [TBL] [Abstract][Full Text] [Related]
10. Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells. Dietrich T; Hucko T; Schneemann C; Neumann M; Menrad A; Willuda J; Atrott K; Stibenz D; Fleck E; Graf K; Menssen HD Atherosclerosis; 2012 Feb; 220(2):329-36. PubMed ID: 22062588 [TBL] [Abstract][Full Text] [Related]
11. Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo. Rademakers T; Douma K; Hackeng TM; Post MJ; Sluimer JC; Daemen MJ; Biessen EA; Heeneman S; van Zandvoort MA Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):249-56. PubMed ID: 23241413 [TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice. Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Bhaskar V; Yin J; Mirza AM; Phan D; Vanegas S; Issafras H; Michelson K; Hunter JJ; Kantak SS Atherosclerosis; 2011 Jun; 216(2):313-20. PubMed ID: 21411094 [TBL] [Abstract][Full Text] [Related]
14. Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. De Vos J; Mathijs I; Xavier C; Massa S; Wernery U; Bouwens L; Lahoutte T; Muyldermans S; Devoogdt N Mol Imaging Biol; 2014 Oct; 16(5):690-8. PubMed ID: 24687730 [TBL] [Abstract][Full Text] [Related]
15. Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. Dunér P; To F; Beckmann K; Björkbacka H; Fredrikson GN; Nilsson J; Bengtsson E Cardiovasc Res; 2011 Aug; 91(3):528-36. PubMed ID: 21493703 [TBL] [Abstract][Full Text] [Related]
16. Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis. Graf K; Dietrich T; Tachezy M; Scholle FD; Licha K; Stawowy P; Grafe M; Hauff P; Fleck E Mol Imaging; 2008; 7(2):68-76. PubMed ID: 18706289 [TBL] [Abstract][Full Text] [Related]
17. The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque. Anderson DR; Tsutsui JM; Xie F; Radio SJ; Porter TR Cardiovasc Res; 2007 Feb; 73(3):597-606. PubMed ID: 17196951 [TBL] [Abstract][Full Text] [Related]
18. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Schwager K; Bootz F; Imesch P; Kaspar M; Trachsel E; Neri D Hum Reprod; 2011 Sep; 26(9):2344-52. PubMed ID: 21705369 [TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of an Park JY; Kim HJ; Chae JR; Cho YL; Kang WJ Biochem Biophys Res Commun; 2024 Apr; 703():149650. PubMed ID: 38377941 [TBL] [Abstract][Full Text] [Related]
20. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice. Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]